# Using "PET Response Criteria in Solid Tumors (PERCIST)" in Evaluating Response to Neoadjuvant Chemoradiotherpy for Esophageal Cancer

> **NCT01927978** · — · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Esophageal Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01927978
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-10
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2014-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01927978

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01927978, "Using "PET Response Criteria in Solid Tumors (PERCIST)" in Evaluating Response to Neoadjuvant Chemoradiotherpy for Esophageal Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01927978. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*